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Family studies of exceptional longevity can potentially identify genetic and other factors contributing to long life
and healthy aging. Although such studies seek families that are exceptionally long lived, they also need living
members who can provide DNA and phenotype information. On the basis of these considerations, the authors
developed a metric to rank families for selection into a family study of longevity. Their measure, the family longevity
selection score (FLoSS), is the sum of 2 components: 1) an estimated family longevity score built from birth-,
gender-, and nation-speciﬁc cohort survival probabilities and 2) a bonus for older living siblings. The authors
examined properties of FLoSS-based family rankings by using data from 3 ongoing studies: the New England
Centenarian Study, the Framingham Heart Study, and screenees for the Long Life Family Study. FLoSS-based
selection yields families with exceptional longevity, satisfactory sibship sizes and numbers of living siblings, and
high ages. Parameters in the FLoSS formula can be tailored for studies of speciﬁc populations or age ranges or
with different conditions. The ﬁrst component of the FLoSS also provides a conceptually sound survival measure to
characterize exceptional longevity in individuals or families in various types of studies and correlates well with later-
observed longevity.
aged, 80 and over; family data; longevity; Shannon information
Abbreviations: FLoSS, family longevity selection score; FRS, family risk score.
Exceptional longevity strongly aggregates in families
(1–4). Thus, studies of exceptionally long-lived
families have the potential to identify genetic variants and
other factors contributing to longevity, particularly
factors that are too rare to detect in a population-based study
(5, 6). Both a family’s exceptionality of survival and its
number of living siblings contribute to its value for a genetic
study of longevity. A challenge in selecting families for such
studies is that the most long-lived individuals may have few
or no living siblings to provide DNA and other
biologic material. To select families for a study of environ-
mental and genetic factors contributing to longevity, we
developed the family longevity selection score (FLoSS).
The FLoSS combines a measure of the exceptionality of
a family’s survival with a bonus for the presence of living
old members; it is computed from information that can be
collected relatively easily from an immediate family
member.
We compare the FLoSS with an alternative scoring
method, the family risk score (FRS). The FRS generalizes
the family history score (7) to quantitative phenotypes, creating
an average score among family members adjusted for the
distribution of the phenotype in the general population (8, 9).
We compare the FLoSS and FRS with regard to charac-
teristics of sibships that would be selected by choosing the
highest scoring sibships according to the following: sibship
size, numbers of living siblings, mean age, and exceptionality
of sibship survival. We compare these characteristics in 2 US
populations selected for longevity (the Long Life Family
Study and the New England Centenarian Study) and in 1
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not selected for longevity (the Framingham Heart Study),
a geographically based US cohort.
MATERIALS AND METHODS
Metric of estimated survival exceptionality for a family
We define both a family measure of survival exception-
ality that requires knowing the age at death of all members
and a method for estimating this measure when all family
members have not yet died.
We characterize an individual’s ‘‘exceptionality of
longevity’’ at age A via p(A), the probability that a random
person in the same birth cohort survives to at least age A. We
use lnðpðAÞÞ, the information content of the rarity of sur-
vival measured by ‘‘Shannon information’’ (10), as the basis
for an individual’s exceptionality score. The increment in
this function for each additional year of survival rises with
age. For example, the increase in its value for survival past
age 96 years versus 95 years is far greater than the increase
for survival past age 71 years versus age 70 years.
The probability of survival past age A varies by cohort as
specified by year, country of birth, and gender. For example,
on the basis of the US Social Security Administration cohort
life tables (http://www.ssa.gov/OACT/NOTES/as116/
as116LOT.html), the same age can produce very different
exceptionality scores: 2.7 ¼ –ln(0.065) for a woman aged
95 years born in 1910 versus 4.2 ¼ –ln(0.015) for a man
aged 95 years born in 1900. Specifically, an individual’s
exceptionality score at age A is –ln(p(A|C)), where p(A|C)
is the probability of survival past age A for those born into
that person’s country-, birth year-, and gender-specific
cohort C. Of course, exceptionality of longevity is fully
observed only at death.
We next wished to measure the family’s survival excep-
tionality. Note that simply summing the –ln(p) values for
individuals cannot be correct, because these are always pos-
itive; thus, each additional family member, even one who dies
at a young age, would increase the score. Clearly, a family of
2, both living at age 95, is more exceptional than a family of
3, with 2 still living at age 95 plus one who died at age 65.
This suggests that each person’s score should be of the form,
–ln(p) k, where k is chosen so that the expected value of the
score for a randomly selected person is 0. In that case, a fam-
ily member for whom –ln(p) exceeds k increases the family’s
longevity exceptionality, while one who dies younger sub-
tracts. The desired value of k is 1 because, for each cohort,
the probabilities p in a life table are uniformly distributed
on the interval from 0 to 1, and the integral (i.e., mean value)
of –ln(p) over this interval is 1. Thus, we choose
lnðpðAjCÞÞ  1 to measure each member’s survival excep-
tionality for including in a family score, defined as follows:
SEf ¼
X
all family members
ðlnðpðAjCÞÞ  1Þ;
in which all A’s are ages at death.
For a living person of age A, we can calculate A*, an
expected age at death calculated from life tables.
Specifically, A* is a cohort-specific expected age at death,
conditional on survival to age A; then, –ln(p(A*|C)) is an
estimated measure of the person’s exceptionality of survival.
Because exceptional longevity is strongly familial (1, 2,
4–6), those with long-lived siblings are likely to live
longer than life-table calculations suggest. (In this
sense, ln(p(A*|C)) is a conservative estimate of expected
exceptionality in families of interest in longevity studies.)
This leads to the following estimated survival exceptionality
for a family f, in which each member’s contribution increases
the family score only if lnðpðAjCÞÞ for dead members or
lnðpðA*jCÞÞ for living members exceeds 1:
estðSEÞf ¼
X
dead family members
ðlnðpðAjCÞÞ  1Þ
þ
X
living family members
lnpA*jC 1:
Metric incorporating the added value of old living family
members
The score ‘‘estðSEÞf ’’ can be computed with any mix of
living and dead family members. For families with
living members, it is a plausible current estimate of SEf ,
the family’s (ultimate) survival exceptionality. When all have
died, it equals SEf . Although estðSEÞf should be useful for
many purposes, it may not be ideal for selecting families into
a study of familial longevity, because it does not particularly
value additional older living siblings, who provide
more biologic and phenotypic data. Thus, we add a living
siblings’ bonus score that satisfies the following principles:
1. Living family members whose age A is already some-
what exceptional, in the sense that lnðpðAjCÞÞ  1 is
greater than 0, should add to the family’s value
for genetic studies on exceptional survival beyond
the value already captured in their contribution to
estðSEÞf .
2. The amount of added value conferred by these living
family members should be a function of
lnðpðAj CÞÞ  1, where A is their current age, rather
than their expected age at death (A*), since only survival
through age A is certain.
3. Living family members who are still so young that
lnðpðAj CÞÞ  1 is negative should neither add to nor
subtract from the bonus.
This leads us to define the following living sibling bonus:
LBf ¼
X
living family members
maxf0; ½ lnðpðAjCÞÞ  1g:
Adding this to estðSEÞf produces our family longevity selec-
tion score, or FLoSS:
FLoSSf ¼
P
dead family members ðlnðpðAjCÞÞ  1Þ
þPliving family members
lnpA*jC 1
þmaxf0;lnðpðAjCÞÞ  1g:
To illustrate the FloSS calculation, consider a sibship with
an oldest brother born in 1920 and died (at age 88) in 2008,
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while 2 other siblings remain living at the end of 2008:
a brother born in 1921 (aged 87 years) and a sister in
1930 (aged 78 years). The US Social Security Administra-
tion cohort life tables indicate that only about 12.2% of the
brothers’ cohort (males born between 1916 and 1925) lives
past 88 and 14.3% lives past 87, while 57.4% of the females
of the sister’s cohort (born between 1926 and 1935) lives
past 78. Furthermore, the living brother is expected to
achieve age A* ¼ 91, while the sister’s A* is 88. The FLoSS
is the sum of their 3 scores. Note that ln(0.122)  1 ¼
2.104  1 ¼ 1.104 is the score for the dead sibling, while for
each of the 2 living siblings the score is computed as
lnðpðA*jCÞÞ  1 þ maxf0;lnðpðAjCÞÞ  1g. From the
US cohort tables, lnðpðA* ¼ 91j1920;mÞÞ  1 ¼ 1:685,
while lnðpðA ¼ 87j1920;mÞÞ  1 ¼ 0:942; so that
6 ¼ maxf0;lnðpðA ¼ 87j1920;mÞÞ  1g ¼ 0:942 . Simi-
larly, lnðpðA* ¼ 88j1930; f ÞÞ  1 ¼ 1:253  1 ¼ 0:253,
while 6 ¼ lnðpðA ¼ 78j1930; f ÞÞ  1 ¼ 0:445 and
maxf0;lnðpðA ¼ 78j1930; f ÞÞ  1g ¼ 0. These values
lead to an est(SE) for the sibship of 3.042 ¼ 1.104 þ
1.685 þ 0.253, a living siblings’ bonus of 0.942 þ 0, and
a FLoSS of 3.984. Additional sibships with various survival
patterns and high FLoSS scores are described and illus-
trated in supplementary material (Web Figure 1). (This
information is posted on the Journal’s website (http://
aje.oxfordjournals.org/).)
An additional consideration is whether to exclude from
scoring those family members who died before some age A0
and, if so, what age. Factors to consider include the quality
of data on deaths in infancy and the survival phenotype of
principal interest, for example, survival from birth, survival
conditional on reaching maturity, or survival conditional on
reaching a specified older age. In the Long Life Family
Study, given our focus on exceptional familial survival over
the life span, we calculated survival conditional on reaching
age 40 (rather than a younger age), on the basis of several
considerations. First, in the early 20th century, deaths below
age 2 were often not recorded. Furthermore, in our study
cohorts, infectious disease epidemics and wars were prom-
inent contributors to mortality in infancy, adolescence, and
early maturity. Moreover, the role of familial factors in
survival below age 40 is unclear (2). Hence, we calculated
pðAjCÞ in our analyses as the ‘‘probability of survival to age
A, conditional upon survival to age A0 ¼ 40.’’ We computed
this from population birth cohort life tables, using only the
subjects alive at age 40 as the referent population. We provide
gender- and US birth cohort-specific scores for those who
survived to at least age 40 in the online supplementary ma-
terial (Web Table 1; refer to the Journal’s website) and on the
Long Life Family Study website (https://longlifefamilystudy.
wustl.edu/FLoSS).
Regarding the actual or expected ages at death required
for individuals to make a positive contribution to this score,
we note that 1  lnð0:37Þ, so that lnðpðAjCÞÞ  1 is only
greater than 0 when p is smaller than 0.37, so that a positive
score is achieved only when longevity exceeds the 63rd
percentile for members of the same gender/birth year cohort
who survived until at least age 40. In the 1900 birth cohort,
for example, this corresponds to 77 years for males and 87
for females.
Comparing the FLoSS and the FRS
A FRS can be generated for quantitative phenotypes, ad-
justing for family size and the distribution of the phenotype
in the general population (8, 9). When applied to longevity
in sibships, the FRS is the average over all siblings in a fam-
ily of their individual scores, S, where:
Figure 1. Characteristics of Long Life Family Study sibships in 2007
as ranked by the family longevity selection score (FLoSS) (A) and the
family risk score (FRS) (B). These plots show the relation between the
percentile ranking of the sibships screened for the Long Life Family
Study based on the estimated survival exceptionality, est(SE), on the
y axis and the percentile ranking based on the family longevity
selection score on the x axis of part A and the family risk score on
the x axis of part B. Diagonal lines represent least-square regression
lines and 95% conﬁdence bounds. Note that the 3 lines essentially
overlap in the plot of part A.
A Family Longevity Selection Score 1557
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S ¼ ðA A˜Þﬃﬃﬃ˜
A
p ; if the sibling is dead; and
¼ maxð0; ðA A˜Þﬃﬃﬃ˜
A
p Þ; if the sibling is alive;
where A denotes the current age (or age at death) of the
sibling, and A˜ is the sex/birth year cohort-adjusted life ex-
pectancy of that sibling. Note that, in long-lived sibships,
each still-living but younger-than-average sibling pulls the
FRS toward 0. In addition, the FRS scores a family with 2
exceptional siblings identically to a family with 4 or 8 sib-
lings, each pair of which is just as exceptional as the 2.
Characteristics of populations used to compare FLoSS
and FRS
We calculated these scores in 3 sibship samples. Only the
first 2 are enriched for longevity.
Sample 1: 660 sibships from the New England Centenar-
ian Study—a nationwide-based sample of centenarians,
their siblings, and offspring. In all selected sibships, the
proband was aged 100 years. In 2005, 49% of all sib-
lings were still living, 33% of the sibships contained at
least 1 living member, and the average attained age was
91 years.
Sample 2: 1,671 US sibships from the screening pilot
phase of the Long Life Family Study—a US–Danish
study of long-lived sibships and their offspring (https://
longlifefamilystudy.wustl.edu/). Sibships of living pro-
bands who were at least 80 years of age were screened in
the US component of the Long Life Family Study. In 2007,
58% of all siblings were still living, all sibships contained at
least 1 living member (the proband who provided data on
the other siblings), and the average age was 83 years.
Sample 3: 766 sibships from the Framingham Heart Study
(11)—a sample of longitudinally followed subjects and
their families. The Framington Heart Study has enrolled
subjects born from 1888 onward; all our sibships had at
least 1 sibling born before 1925. In 2004, 13% of all sib-
lings were still living, 21% of the sibships contained at
least 1 living member, and the average attained age was
74 years.
Cohort, survivorship, and sibship data
For the New England Centenarian Study, Framington
Heart Study, and Long Life Family Study sibships, we esti-
mated gender/birth-year survival functions and calculated the
Table 1. Age and Size Distributions of Low- and High-ranked Sibship Cohorts in the Long Life
Family Study, by Ranking Method, in 2007a
Siblings Included and
Ranking Method
Sibship Age, years
Lowest Ranked 40% Highest Ranked 5%
Mean Median % >90 Years Mean Median % >90 Years
All
FLoSS 80.6 81.0 6 92.8 92.5 67
FRS 78.9 79.5 0 99.9 99.0 100
Living only
FLoSS 85.0 85.0 16 95.8 95.8 87
FRS 84.8 84.5 13 100.0 100.0 100
Sibship Size, no.
Lowest Ranked 40% Highest Ranked 5%
Mean Median % >1 Sibling Mean Median % >1 Sibling
All
FLoSS 3.0 3.0 75 5.3 5.0 95
FRS 4.0 4.0 91 1.3 1.0 20
Living only
FLoSS 1.7 1.0 44 3.0 3.0 79
FRS 2.4 2.0 64 1.0 1.0 3
Abbreviations: FLoSS, family longevity selection score; FRS, family risk score.
a Summary statistics of size and age of sibships ranked in the lowest 40% and the top 5% by the
FLoSS or the FRS in the Long Life Family Study. In each of the 4 pairs of rows, the ﬁrst describes
sibships as ranked by the FLoSS and the second, by the FRS. Age statistics describe the average
achieved ages (either age at death or current age), for either all siblings or only living ones, as
indicated, in the included sibships. All differences in sibship age and size for the FRS versus
FLoSS top groups were signiﬁcant (P < 0.001; Wilcoxon test).
1558 Sebastiani et al.
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expected age at death (A*) using the Social Security Admin-
istration cohort life tables for successive birth decades, with
the 1900 tables for births from 1895 through 1904, the 1910
tables for births from 1905 through 1914, and so on. These
tables are available at http://www.ssa.gov/OACT/NOTES/
as116/as116LOT.html. In the Long Life Family Study data,
siblings with unknown vital status were considered to be
dead, with the age at death given (conservatively) as the
age at last contact. For an unknown birth year, we used the
youngest sibling’s birth year. Both siblings and half-siblings
were included in FLoSS score calculations.
Statistical analysis
We estimated Spearman correlations between the percen-
tile ranking based on estðSEÞf and the FLoSS and FRS. We
used summary statistics to illustrate differences between
sibships in the lowest 40 percentile groups and in the top
5%, as defined by each score, and Wilcoxon and t statistics
to test for their significance. Reported P values are 2 sided.
RESULTS
As shown in Figure 1, the percentile ranking of families
screened for the Long Life Family Study based on estðSEÞf ,
the estimated ‘‘survival exceptionality,’’ is more strongly
correlated with the rankings based on the FLoSS (r ¼
0.98) (Figure 1A) than with those based on the FRS (r ¼
0.71) (Figure 1B). As seen in Table 1, the sibships ranked in
the top 5% by the FLoSS and FRS have quite different
characteristics. Sibships ranked in the top 5% by the FRS
average between 4 and 7 years older but are far smaller than
those ranked in the top 5% by the FLoSS. Note that 79% of
the sibships ranked in the top 5% by the FLoSS have more
than 1 living sibling compared with only 3% of the sibships
ranked in the top 5% by the FRS.
Figure 2 shows the distribution of the FLoSS and FRS in
the sibships of the Framington Heart Study (left), the Long
Life Family Study (middle), and the New England Cente-
narian Study (right). For comparability, the FLoSS and FRS
scores in the Long Life Family Study and the New England
Centenarian Study are each standardized to their distribu-
tions in the Framington Heart Study, a sample that is not
enriched for longevity. In contrast, the New England Cen-
tenarian Study recruited families with centenarians, result-
ing in a strongly shifted distribution of the standardized
FLoSS scores. The FLoSS distribution for the Long Life
Family Study screening population is intermediate, because
it includes families with some evidence of longevity. The
standardized FRS score distributions also shift to the right in
the Long Life Family Study and New England Centenarian
Figure 2. Distribution of the standardized family longevity selection score (S-FLoSS) and the standardized family risk score (S-FRS) for sibships
from the Framingham Heart Study (FHS), the Long Life Family Study (LLFS) screenees, and the New England Centenarian Study (NECS).
S-FLoSS is deﬁned as (FLoSSM )/S, whereM ¼ 0.24 and S ¼ 1.47 are, respectively, the mean and standard deviation of FLoSS scores in the
FHS cohort. S-FRS is deﬁned analogously (i.e., as a z score in the same cohort, with M ¼ 1.98 and S ¼ 1.30). Parameters l and r in each panel
are the mean and standard deviation of standardized scores. Dashed lines represent the standard normal density, and dotted lines represent the
normal density with mean and standard deviation of the S-FLoSS and S-FRS. The S-FLoSS values for the LLFS and NECS sibships are
signiﬁcantly different from the S-FLoSS values for the FHS sibships (P < 0.0000; Wilcoxon test). Similarly, the S-FRS values for the LLFS and
NECS sibships are signiﬁcantly different from the S-FRS values for the FHS sibships (P < 0.0000; Wilcoxon test).
A Family Longevity Selection Score 1559
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Study. Indeed, all 3 cohort pairs differ in score distributions
(all P < 0.001; Wilcoxon test). However, the FLoSS distin-
guishes the populations far more sharply. Note that less than
1% of Framington Heart Study sibships have a FLoSS of >7
(standardized FLoSS, >4.95). To focus on unusually long-
lived families, the Long Life Family Study enrolled only
families with a FLoSS of 7 or more.
We also examined the degree to which the FLoSS and
estimated survival exceptionality score predict actual sur-
vival exceptionality (SEf), observed only after all have died.
For those 442 sibships of the New England Centenarian
Study in which at least 1 sibling was alive in 1995 but all
had died by 2004, we computed the FLoSS using data
known in 1995 and the (fully observed) SEf in 2004. The
scatterplot in Figure 3 shows the relation between the
sibships’ rankings based on the 2004 SEf (y axis) and those
based on the FLoSS and on the estimated survival excep-
tionality longevity score, estðSEÞf , in 1995. The ranking
based on the FLoSS and on estðSEÞf in 1995 correlates
equally strongly with the ranking based on the SEf measured
a decade later (both r ¼ 0.90).
DISCUSSION
A sibship’s FLoSS is a good predictor of its true (not yet
fully known) exceptionality of survival. Thus, it is useful for
selecting long-lived families for studies of genetic and non-
genetic factors contributing to longevity. In particular, the
FLoSS can identify desirable sibships among families being
screened for genetic epidemiologic studies of exceptional
longevity. Sibships with a high FLoSS have high ages of the
total sibship and of living siblings, as well as high numbers
of total and living members.
A high FLoSS can be achieved by the presence of a single
individual with extremely long survival (if the other siblings
are not short lived) or by the presence of many long (but not
extremely)-lived siblings. The modes of transmission of
longevity (if any) associated with these types of patterns
may differ. For example, the former might reflect a recessive
trait; the latter, a dominant. The fact that a high FLoSS value
captures both of these patterns is one of its strengths, be-
cause it does not exclude longevous families who might not
be ascertained by other methods (e.g., setting a single ex-
tremely exceptional age for inclusion of individuals or sib-
lings). However, the additional potential heterogeneity of
genetic factors captured in high-FLoSS families implies
a need for attention to potential differences among sub-
groups in genetic transmission.
We used the FLoSS to score families defined as members
of a single sibship. Although it could be used to score multi-
generational groups of relatives, gathering complete infor-
mation on the parents of old siblings or on widely dispersed
groups of near relatives could be challenging. Furthermore,
young people contribute little information regarding
ultimate survival.
In the Long Life Family Study, we set the minimum
FLoSS for a family to be eligible at 7. This threshold was
chosen by observing that only 0.2% of the FLoSS sibships
of the Framington Heart Study meet this threshold, in con-
trast to over 30% of the Long Life Family Study screening
families and over 40% of families enrolled in the New
England Centenarian Study. Thus, families with a FloSS as
large as 7 are extremely rare but findable. Calculation of
FLoSS scores in families from additional population-based
samples can provide further guidance about appropriate
selection thresholds.
The FLoSS is the sum of estðSEÞf and LBf (the living
bonus). Its first component is a current estimate of a family’s
ultimate, ‘‘fully observed,’’ survival exceptionality, SEf. Al-
though the living bonus enables the FLoSS to select families
that are more desirable for genetic epidemiologic studies of
exceptional longevity, estðSEÞf may be a better intrinsic
measure of family longevity. As such, estðSEÞf may be par-
ticularly useful for examining relations of genotypes and
other risk factors to phenotypes of family members and their
family’s exceptionality of survival, or for finding subsets of
populations that are similar with respect to the exception-
ality of their families. Although in our comparison the
FLoSS and estðSEÞf correlated equally well with the ob-
served SEf 10 years later, this may not apply over longer
intervals. Note that, when all family members have died, all
3 measures coincide.
The FLoSS as used in the Long Life Family Study can be
viewed as a member of a class of family scores that combine
an estimated exceptionality of survival with a bonus for
living siblings, as in the following:
Figure 3. Rankings for survival exceptionality versus family longevity
selection score (FLoSS) and estimated survival exceptionality (est(SE))
among 442 New England Centenarian Study sibships with ﬁnal
survivors’ deaths within 10 years after 1995. For each of the 442
New England Centenarian Study sibships with at least 1 living member
in 1995 and none in 2004, an open circle relates its percentile ranking
based on observed survival exceptionality in 2004 on the y axis to its
1995 family longevity selection score percentile ranking on the x axis.
Stars show the same relation for a sibship’s percentile ranking based
on survival exceptionality in 2004 (on the y axis) and percentile ranking
based on its 1995 estimated survival exceptionality on the x axis.
1560 Sebastiani et al.
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Longevity selection score ¼ estðSEÞf þ w3LBf ;
where estðSEÞf is of the form,X
dead family members
ðlnðpðAjCðaÞÞÞ  kÞ
þ
X
living family members
lnpA*jCa k:
Here, w and k are nonnegative constants, C(a) is a person-
specific reference cohort of those born around the same time
who survived to some minimum age, a, and LBf is a non-
negative bonus for older living siblings. Each parameter can
be tailored to the particular needs of other studies.
For the FLoSS, we chose w ¼ 1, C(a) ¼ all people in the
same birth-year, gender, and national cohort who survived to
at least age 40, k ¼ 1, and
LBf ¼
X
living family members maxf0; ½  lnðpðAjCðaÞÞÞ  1g:
An age threshold other than 40 years could be chosen
depending on a study’s focus (e.g., age 70 to study factors
influencing survival only in advanced age). Choosing
w ¼ 1 weights the estimated survival exceptionality and
living bonus equally; w ¼ 0 yields estðSEÞf , a measure of
family survival exceptionality alone. Note that the ex-
pected value of estðSEÞf for a ‘‘pseudofamily’’ constructed
by grouping N randomly selected individuals from the
US population is N 3 (1 – k). Choosing k ¼ 1 makes
estðSEÞf neutral to sibship size, because its expected value
should be 0 for randomly selected (not particularly long-
lived) people. The ‘‘neutrality’’ of the FLoSS was vali-
dated by the fact that its average in the geography-based
Framingham Heart Study cohort was quite close to 0.
Because –ln(0.37) is approximately equal to 1, only ages
in the top 37th percentile add to estðSEÞf . More generally,
values of k smaller than 1 favor larger families (because
each ‘‘typical’’ person’s expected score is positive), while
choosing k larger than 1 favors smaller ones. If greater
exceptionality is sought, a larger cutoff for the FLoSS
could be used.
We chose w ¼ 1, giving equal weight to the estimated
exceptionality score and the ‘‘bonus’’ for living older family
members. This reflected our interest in both survival excep-
tionality and the availability of old living study subjects.
With this choice, the FLoSS still correlates strongly with
estðSEÞf as we wanted. Larger w’s will give more weight to
the living bonus and reduce the correlation with estðSEÞf .
In summary, we have introduced and examined the
consequences of a conceptually attractive framework for
family longevity studies. These include 1) a measure of an
individual’s exceptionality of survival, 2) a feasible way to
estimate that exceptionality for those still alive, 3) a size-
neutral way to combine individual scores into a family
score, 4) a plausible bonus measure for the additional value
of already exceptional living family members, and 5) a way
to balance interest in older living relatives and family sur-
vival exceptionality in a single score such as the FLoSS.
This framework should be useful in many settings. We also
note that formulas for the FLoSS and estðSEÞf could be
adapted to measure exceptionality of survival until other
events besides death. Thus, we could quantify family risk
for the onset of conditions (such as stroke or onset of
diabetes or disability) whose incidence rises with age. We
are investigating this idea.
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